Literature DB >> 23530176

Mutation in the SLC29A3 gene: a new cause of a monogenic, autoinflammatory condition.

Isabelle Melki1, Karen Lambot, Laurence Jonard, Vincent Couloigner, Pierre Quartier, Bénédicte Neven, Brigitte Bader-Meunier.   

Abstract

Germline mutations in the SLC29A3 gene result in a range of recessive, clinically related syndromes: H syndrome, pigmented hypertrichosis with insulin-dependent diabetes mellitus syndrome, Faisalabad histiocytosis, and sinus histiocytosis with massive lymphadenopathy. The main symptoms of these diseases are hyperpigmentation with hypertrichosis, sensorineural deafness, diabetes, short stature, uveitis, and Rosai-Dorfman like histiocytosis. Here, we report the case of an 11-month-old boy with early-onset, recurrent episodes of unprovoked fever lasting 7 to 10 days and associated with pericardial effusion, abdominal pain, diarrhea, and inflammation. Physical examination revealed hyperpigmentation with hypertrichosis, dysmorphic features, and spleen and liver enlargement. Failure to thrive, sensorineural deafness, retarded psychomotor development, and a Rosai-Dorfman like cheek lesion developed subsequently. The febrile episodes did not respond to tumor necrosis factor α antagonists and interleukin-1. Sequencing of the SLC29A3 gene revealed a homozygous missense mutation c.1088G>A (p.Arg363Gln). These observations suggest that a newly identified mutation in the SLC29A3 gene may be associated with an autoinflammatory disorder. Genetic defects in SLC29A3 should be considered in patients with autoinflammatory manifestations, recurrent febrile attacks, and 1 or more of the symptoms found in the broad spectrum of SLC29A3-related disorders (especially hyperpigmentation with hypertrichosis).

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23530176     DOI: 10.1542/peds.2012-2255

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  20 in total

Review 1.  Equilibrative nucleoside transporters-A review.

Authors:  Rebba C Boswell-Casteel; Franklin A Hays
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2016-10-19       Impact factor: 1.381

2.  A Case of SLC29A3 Spectrum Disorder-Unresponsive to Multiple Immunomodulatory Therapies.

Authors:  Anoop Mistry; David Parry; Bipin Matthews; Philip Laws; Mark Goodfield; Sinisa Savic
Journal:  J Clin Immunol       Date:  2016-05-23       Impact factor: 8.317

Review 3.  Geoepidemiology and Immunologic Features of Autoinflammatory Diseases: a Comprehensive Review.

Authors:  Yvan Jamilloux; Alexandre Belot; Flora Magnotti; Sarah Benezech; Mathieu Gerfaud-Valentin; Emilie Bourdonnay; Thierry Walzer; Pascal Sève; Thomas Henry
Journal:  Clin Rev Allergy Immunol       Date:  2018-06       Impact factor: 8.667

4.  Mutation in the SLC29A3 Gene in an Egyptian Patient with H Syndrome: A Case Report and Review of Literature.

Authors:  Hala T El-Bassyouni; Manal M Thomas; Angie M S Tosson
Journal:  J Pediatr Genet       Date:  2019-09-30

Review 5.  Molecular mechanisms in genetically defined autoinflammatory diseases: disorders of amplified danger signaling.

Authors:  Adriana Almeida de Jesus; Scott W Canna; Yin Liu; Raphaela Goldbach-Mansky
Journal:  Annu Rev Immunol       Date:  2015-02-20       Impact factor: 28.527

Review 6.  Untangling the web of systemic autoinflammatory diseases.

Authors:  Donato Rigante; Giuseppe Lopalco; Antonio Vitale; Orso Maria Lucherini; Francesco Caso; Caterina De Clemente; Francesco Molinaro; Mario Messina; Luisa Costa; Mariangela Atteno; Franco Laghi-Pasini; Giovanni Lapadula; Mauro Galeazzi; Florenzo Iannone; Luca Cantarini
Journal:  Mediators Inflamm       Date:  2014-07-15       Impact factor: 4.711

7.  Identification of a novel mutation in solute carrier family 29, member 3 in a Chinese patient with H syndrome.

Authors:  Jia-Wei Liu; Nuo Si; Lian-Qing Wang; Ti Shen; Xue-Jun Zeng; Xue Zhang; Dong-Lai Ma
Journal:  Chin Med J (Engl)       Date:  2015-05-20       Impact factor: 2.628

8.  Patient with H syndrome, cardiogenic shock, multiorgan infiltration, and digital ischemia.

Authors:  Laura Ventura-Espejo; Inés Gracia-Darder; Silvia Escribá-Bori; Eva Regina Amador-González; Ana Martín-Santiago; Jan Ramakers
Journal:  Pediatr Rheumatol Online J       Date:  2021-06-30       Impact factor: 3.054

9.  High-density P300 enhancers control cell state transitions.

Authors:  Steven Witte; Allan Bradley; Anton J Enright; Stefan A Muljo
Journal:  BMC Genomics       Date:  2015-11-06       Impact factor: 3.969

Review 10.  The expanding spectrum of rare monogenic autoinflammatory diseases.

Authors:  Isabelle Touitou; Caroline Galeotti; Linda Rossi-Semerano; Véronique Hentgen; Maryam Piram; Isabelle Koné-Paut
Journal:  Orphanet J Rare Dis       Date:  2013-10-16       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.